Annual report pursuant to Section 13 and 15(d)

Net Loss per Share of Common Stock

v3.23.1
Net Loss per Share of Common Stock
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Net Loss per Share of Common Stock

Note 7 – Net Loss per Share of Common Stock

 

Basic net loss per share is computed by dividing net loss by the weighted average common stock outstanding (which excludes unvested RSAs) and vested RSUs. Diluted net loss per share is computed by dividing net loss by the diluted weighted average common stock outstanding, which includes potentially dilutive effect of stock options, unvested RSAs, unvested RSUs and warrants. Since we experienced a loss for both periods presented, basic and diluted net loss per share are the same and, as they would have an anti-dilutive impact on diluted net loss per share, any dilutive common shares outstanding were excluded from the computation shown below.

 

The computation of net loss per share for the year ended December 31, 2022 and 2021 was as follows:

 

    2022     2021  
Basic and diluted net loss per share:                
Net loss available to common shareholders   $ (27,424,229 )   $ (11,427,534 )
Weighted-average number of common shares-basic and diluted     16,109,291       15,319,463  
                 
Basic and diluted net loss per share   $ (1.70 )   $ (0.75 )

 

As described in Note 5, we issued various equity instruments during the years ended December 31, 2022 and 2021 which impact our EPS calculation. All granted RSAs are considered issued and outstanding for purposes of our financial statements. Unvested RSAs are included as dilutive securities, but are excluded from our denominator of basic EPS. At December 31, 2022 and 2021, 61,888 and 91,109 RSAs, respectively, were not vested and were excluded from the EPS calculation. Vested RSUs are include in our computation of the weighted average shares for basic EPS and unvested RSUs are included as dilutive securities. At December 31, 2022 and 2021, 2,051,908 and 249,100 unvested RSUs were excluded from the EPS calculation.

 

The outstanding stock options, unvested RSAs, unvested RSUs and warrants to purchase common stock were excluded from the computation of diluted net loss per share as their effect would have been anti-dilutive for the periods presented below:

 

    2022     2021  
Stock options, unvested RSAs, unvested RSUs and purchase warrants     2,577,910       822,430  

 

The calculation of potentially dilutive securities at December 31, 2022 excludes the 1,056,503 RSAs and RSUs granted to employees and directors on January 1, 2023 and the warrants for 3,160,130 shares of our common stock, which will be issued to Spartan in April 2023 in connection with our extended consulting agreement. Basic net loss per share is computed by dividing net loss by the weighted average common shares outstanding. Diluted net loss per share is computed by dividing net loss by the weighted average common shares outstanding without the impact of potential dilutive common shares outstanding because they would have an anti-dilutive impact on diluted net loss per share. The treasury-stock method is used to determine the dilutive effect of our stock options and warrants grants.